Calcium-binding proteins in focal cortical dysplasia

Epilepsia

Volumn 56, Issue 8, 2015, Pages 1207-1216

  Kuchukhidze, Giorgi ^a,b   Wieselthaler Hölzl, Anna ^a   Drexel, Meinrad ^a   Unterberger, Iris ^a   Luef, Gerhard ^a   Ortler, Martin ^a   Becker, Albert J ^c   Trinka, Eugen ^a,b   Sperk, Günther ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Calcium binding proteins; Focal cortical dysplasia; Temporal lobe epilepsy

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; FLUORODEOXYGLUCOSE; PARVALBUMIN; 4 AMINOBUTYRIC ACID RECEPTOR;

ADULT; ARTICLE; BRAIN CELL; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; ELECTROENCEPHALOGRAM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SEIZURE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; ADOLESCENT; CASE CONTROL STUDY; COMPLICATION; CYTOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; TEMPORAL LOBE; YOUNG ADULT;

ADOLESCENT; ADULT; CALBINDIN 2; CALBINDINS; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CELL COUNT; EPILEPSY, TEMPORAL LOBE; FEMALE; GABAERGIC NEURONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MIDDLE AGED; PARVALBUMINS; TEMPORAL LOBE; YOUNG ADULT;

EID: 84938741668     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13053     Document Type: Article

References (26)

1. Blumcke I, Thom M, Aronica E, et al., The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52: 158-174.
2. Colombo N,. Imaging of malformations of cortical development. 2009.
3. Huppertz HJ, Kurthen M, Kassubek J,. Voxel-based 3D MRI analysis for the detection of epileptogenic lesions at single subject level. Epilepsia 2009; 50: 155-156.
4. Wagner J, Weber B, Urbach H, et al., Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain 2011; 134: 2844-2854.
5. Colombo N, Tassi L, Galli C, et al., Focal cortical dysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy. AJNR Am J Neuroradiol 2003; 24: 724-733.
6. Andrioli A, Alonso-Nanclares L, Arellano JI, et al., Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus. Neuroscience 2007; 149: 131-143.
7. Barinka F, Druga R, Marusic P, et al., Calretinin immunoreactivity in focal cortical dysplasias and in non-malformed epileptic cortex. Epilepsy Res 2010; 88: 76-86.
8. Garbelli R, Meroni A, Magnaghi G, et al., Architectural (Type IA) focal cortical dysplasia and parvalbumin immunostaining in temporal lobe epilepsy. Epilepsia 2006; 47: 1074-1078.
9. Zamecnik J, Krsek P, Druga R, et al., Densities of parvalbumin-immunoreactive neurons in non-malformed hippocampal sclerosis-temporal neocortex and in cortical dysplasias. Brain Res Bull 2006; 68: 474-481.
10. D'Orlando C, Fellay B, Schwaller B, et al., Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res 2001; 909: 145-158.
11. D'Orlando C, Celio MR, Schwaller B,. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res 2002; 945: 181-190.
12. Figueredo-Cardenas G,. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. 1998.
13. Kuruba R, Hattiangady B, Parihar VK, et al., Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity. PLoS ONE 2011; 6: e24493.
14. Scharfman HE,. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. 1989.
15. Kuchukhidze G, Koppelstaetter F, Unterberger I, et al., Hippocampal abnormalities in malformations of cortical development: MRI study. Neurology 2010; 18 (74): 1575-1582.
16. Paxinos G, Warson C,. The rat brain: stereotaxic coordinates. Sydney, NSW: Academic Press; 1986.
17. Sperk G, Wieselthaler-Holzl A, Pirker S, et al., Glutamate decarboxylase67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients. Hippocampus 2012; 22: 590-603.
18. Beasley CL, Zhang ZJ, Patten I, et al., Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 2002; 52: 708-715.
19. Chiry O, Tardif E, Magistretti PJ, et al., Patterns of calcium-binding proteins support parallel and hierarchical organization of human auditory areas. Eur J Neurosci 2003; 17: 397-410.
20. Spreafico R, Battaglia G, Arcelli P, et al., Cortical dysplasia: an immunocytochemical study of three patients. Neurology 1998; 50: 27-36.
21. Hof PR, Glezer II, Conde F, et al., Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns. J Chem Neuroanat 1999; 16: 77-116.
22. Bu J, Sathyendra V, Nagykery N, et al., Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Exp Neurol 2003; 182: 220-231.
23. Mathern GW, Mendoza D, Lozada A, et al., Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 1999; 52: 453-472.
24. Proper EA, Hoogland G, Kappen SM, et al., Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2002; 125: 32-43.
25. A receptors in the neocortex of patients with focal epilepsy. Brain 2006; 129: 3277-3289.
26. Drexel M, Preidt AP, Kirchmair E, et al., Parvalbumin interneurons and calretinin fibers arising from the thalamic nucleus reuniens degenerate in the subiculum after kainic acid-induced seizures. Neuroscience 2011; 189: 316-329.